BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30695465)

  • 1. [Hepatitis B Virus Infection: Current Management and Prevention].
    Inoue T; Tanaka Y
    Rinsho Byori; 2016 Jul; 64(7):771-779. PubMed ID: 30695465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Latest Treatment of Viral Hepatitis--Overcoming Hepatitis C and Reactivation of Hepatitis B].
    Tanaka Y
    Rinsho Byori; 2016 Feb; 64(2):211-8. PubMed ID: 27311286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus and its sexually transmitted infection - an update.
    Inoue T; Tanaka Y
    Microb Cell; 2016 Sep; 3(9):420-437. PubMed ID: 28357379
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel monitoring of hepatitis B reactivation based on ultra-high sensitive hepatitis B surface antigen assay.
    Shinkai N; Kusumoto S; Murakami S; Ogawa S; Ri M; Matsui T; Tamori A; Toyoda H; Ishida T; Iida S; Tanaka Y
    Liver Int; 2017 Aug; 37(8):1138-1147. PubMed ID: 27992664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study.
    Kusumoto S; Tanaka Y; Suzuki R; Watanabe T; Nakata M; Takasaki H; Fukushima N; Fukushima T; Moriuchi Y; Itoh K; Nosaka K; Choi I; Sawa M; Okamoto R; Tsujimura H; Uchida T; Suzuki S; Okamoto M; Takahashi T; Sugiura I; Onishi Y; Kohri M; Yoshida S; Sakai R; Kojima M; Takahashi H; Tomita A; Maruyama D; Atsuta Y; Tanaka E; Suzuki T; Kinoshita T; Ogura M; Mizokami M; Ueda R
    Clin Infect Dis; 2015 Sep; 61(5):719-29. PubMed ID: 25935551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of occult hepatitis B virus infection in children born to HBsAg-positive mothers despite prophylaxis with hepatitis B vaccination and HBIG.
    Shahmoradi S; Yahyapour Y; Mahmoodi M; Alavian SM; Fazeli Z; Jazayeri SM
    J Hepatol; 2012 Sep; 57(3):515-21. PubMed ID: 22617152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risk Management of HBV Reactivation: Construction of Check System].
    Tanaka Y
    Rinsho Byori; 2015 Sep; 63(9):1052-9. PubMed ID: 26731893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B vaccination and prevention of hepatocellular carcinoma.
    Kao JH
    Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):907-17. PubMed ID: 26651252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel strategies for the early diagnosis of hepatitis B virus reactivation.
    Inoue T; Matsui T; Tanaka Y
    Hepatol Res; 2021 Oct; 51(10):1033-1043. PubMed ID: 34272919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus vaccine breakthrough infection: surveillance of S gene mutants of HBV.
    Qin Y; Liao P
    Acta Virol; 2018; 62(2):115-121. PubMed ID: 29895151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for and management of hepatitis B virus reactivation in patients treated with anti-B-cell therapy.
    Kusumoto S; Tobinai K
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):576-83. PubMed ID: 25696914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occult hepatitis B virus infection.
    Allain JP
    Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B vaccination in children: the Taiwan experience.
    Ni YH; Chen DS
    Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NIH consensus development statement on management of hepatitis B.
    Belongia EA; Costa J; Gareen IF; Grem JL; Inadomi JM; Kern ER; McHugh JA; Petersen GM; Rein MF; Sorrell MF; Strader DB; Trotter HT
    NIH Consens State Sci Statements; 2008 Oct 22-24; 25(2):1-29. PubMed ID: 18949020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical Significance of Novel Serum Biomarkers in the Management of Liver Diseases].
    Inoue T; Tanaka Y
    Rinsho Byori; 2017 Jan; 65(1):83-91. PubMed ID: 30695516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of vaccine-acquired polyclonal anti-HBs antibodies on the prevention of HBV infection of non-vaccine genotypes.
    Kato M; Hamada-Tsutsumi S; Okuse C; Sakai A; Matsumoto N; Sato M; Sato T; Arito M; Omoteyama K; Suematsu N; Okamoto K; Kato T; Itoh F; Sumazaki R; Tanaka Y; Yotsuyanagi H; Kato T; Kurokawa MS
    J Gastroenterol; 2017 Sep; 52(9):1051-1063. PubMed ID: 28197802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
    Yeo W; Chan TC; Leung NW; Lam WY; Mo FK; Chu MT; Chan HL; Hui EP; Lei KI; Mok TS; Chan PK
    J Clin Oncol; 2009 Feb; 27(4):605-11. PubMed ID: 19075267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.
    ;
    J Hepatol; 2017 Aug; 67(2):370-398. PubMed ID: 28427875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
    Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
    Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatocellular carcinoma, hepatitis B virus and the immune system].
    Grob PJ
    Schweiz Med Wochenschr; 1986 Aug; 116(34):1133-45. PubMed ID: 3020684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.